Voyager Therapeutics

Novartis, Voyager launch another gene therapy mission with $100M upfront deal
Fierce Biotech
Tue, 01/2/24 - 10:05 am
Novartis
gene therapy
Voyager Therapeutics
Huntington's disease
SMA
Top biotech licensing deals of Q1 2023
BioSpace
Thu, 03/30/23 - 11:03 am
biotech
licensing
Moderna Therapeutics
CytomX
Voyager Therapeutics
Neurocrine Biosciences
Kronos Bio
Genentech
Karuna Therapeutics
Goldfinch Bio
Novartis ready to head for deep space with Voyager after a year 'kicking the tires'
Fierce Biotech
Mon, 03/6/23 - 11:41 am
Novartis
Voyager Therapeutics
Neurocrine blows fresh wind in Voyager's sails with $175M upfront for CNS capsid collab
Fierce Biotech
Mon, 01/9/23 - 10:34 am
Voyager Therapeutics
Neurocrine
capsids
CNS
Parkinson's Disease
Pfizer pulls trigger on Voyager gene therapy capsid deal, clearing it to fire TRACER at CNS disease
Fierce Biotech
Tue, 10/4/22 - 10:48 am
Pfizer
Voyager Therapeutics
capsids
gene therapy
Ex-Biogen R&D head Sandrock takes the top job at Voyager
Pharmaforum
Tue, 03/22/22 - 10:06 am
Voyager Therapeutics
Biogen
Al Sandrock
R&D
Pharma CEOs
Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?
Motley Fool
Sun, 03/20/22 - 11:03 pm
Pfizer
Novartis
Voyager Therapeutics
AAV capsid
Novartis eyes next-gen AAV gene therapies in $1.75B Voyager biobucks pact
Fierce Biotech
Tue, 03/8/22 - 10:07 am
Novartis
Voyager Therapeutics
biobucks
gene therapy
AAV gene therapy
Parkinson's gene therapy restores responses to dopamine-boosting drug in mouse models
Fierce Biotech
Fri, 11/5/21 - 09:49 am
Parkinson's Disease
Levodopa
gene therapy
Voyager Therapeutics
Bayer
Pfizer agrees $630m deal to harness Voyager’s gene therapy tech
Pharmaforum
Wed, 10/6/21 - 10:46 am
Pfizer
Voyager Therapeutics
gene therapy
FDA says Voyager can trek on as it removes trial hold for Huntington's gene therapy test
Fierce Biotech
Mon, 04/26/21 - 11:15 am
FDA
Voyager Therapeutics
VY-HTT01
gene therapy
Huntington's disease
Neurocrine Terminates Parkinson's Deal with Voyager Following Clinical Hold
BioSpace
Wed, 02/3/21 - 10:57 am
Voyager Therapeutics
Parkinson's Disease
Neurocrine
clinical trials
FDA gene therapy holdups suggest closer scrutiny by agency
BioPharma Dive
Fri, 11/6/20 - 10:07 am
FDA
gene therapy
Sarepta Therapeutics
Voyager Therapeutics
Iovance
Bluebird Bio
Voyager Takes a Hit After FDA Places Hold on Gene Therapy for Huntington's Disease
BioSpace
Tue, 10/13/20 - 11:01 am
Voyager Therapeutics
gene therapy
FDA
Huntington's disease
VY-HTT01
AbbVie cans Voyager Alzheimer’s, Parkinson’s gene therapy pacts
Fierce Biotech
Tue, 08/4/20 - 11:07 am
AbbVie
Alzheimer's disease
Parkinson's Disease
Voyager Therapeutics
Sanofi Genzyme deserts gene therapy developer Voyager Therapeutics
Endpoints
Mon, 06/17/19 - 11:26 pm
Sanofi Genzyme
Voyager Therapeutics
gene therapy
Voyager Shares Take Off on Parkinson's Disease Development Deal
TheStreet.com
Fri, 02/22/19 - 10:11 am
Voyager Therapeutics
gene therapy
AbbVie
Parkinson's Disease
Neurocrine Pays $165M to Bankroll Voyager’s Gene Therapy for Parkinson’s
Xconomy
Tue, 01/29/19 - 09:59 am
Voyager Therapeutics
Parkinson's Disease
Neurocrine
VY-AADC
gene therapy
Sanofi’s Andre Turenne Is Slated to Become Voyager Therapeutics CEO
Xconomy
Wed, 07/4/18 - 10:12 am
Voyager Therapeutics
Andre Turenne
Sanofi
Pharma CEOs
With $69M Deal, AbbVie Turns to Voyager for an Alzheimer’s Gene Therapy
Xconomy
Tue, 02/20/18 - 10:58 pm
AbbVie
Voyager Therapeutics
gene therapy
Alzheimer's disease

Pages